CSPC Pharmaceuticals Group Ltd., formerly China Pharmaceutical Group Limited, is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacture and sale of pharmaceutical products. The Company is operating in three business segments: manufacture and sale of intermediate and bulk drugs, including vitamin C series and antibiotics series; finished drugs, including amoxicillin and cefazolin in different dosage and form, and other pharmaceutical related business and development activities. As of December 31, 2011, its subsidiaries included Golden Wing Limited, Tin Lon Investment Limited, CSPC Zhongrun Pharmaceutical (Inner Mongolia) Co.,Ltd., CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Inner Mongolia Zhongxingyuan Sewage Treatment Co.,Ltd and others. On July 18, 2013, the Company disposed a direct wholly-owned subsidiary.